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Abstract
Background: The C9ORF72 hexanucleotide repeat expansion is the most common known genetic cause of
amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two fatal age-related neurodegenerative diseases.
The C9ORF72 expansion encodes five dipeptide repeat proteins (DPRs) that are produced through a non-canonical
translation mechanism. Among the DPRs, proline-arginine (PR), glycine-arginine (GR), and glycine-alanine (GA) are the
most neurotoxic and increase the frequency of DNA double strand breaks (DSBs). While the accumulation of these
genotoxic lesions is increasingly recognized as a feature of disease, the mechanism(s) of DPR-mediated DNA damage are
ill-defined and the effect of DPRs on the efficiency of each DNA DSB repair pathways has not been previously evaluated.
Methods and results: Using DNA DSB repair assays, we evaluated the efficiency of specific repair pathways, and found
that PR, GR and GA decrease the efficiency of non-homologous end joining (NHEJ), single strand annealing (SSA), and
microhomology-mediated end joining (MMEJ), but not homologous recombination (HR). We found that PR inhibits DNA
DSB repair, in part, by binding to the nucleolar protein nucleophosmin (NPM1). Depletion of NPM1 inhibited NHEJ and
SSA, suggesting that NPM1 loss-of-function in PR expressing cells leads to impediments of both non-homologous and
homology-directed DNA DSB repair pathways. By deleting NPM1 sub-cellular localization signals, we found that PR binds
NPM1 regardless of the cellular compartment to which NPM1 was directed. Deletion of the NPM1 acidic loop motif,
known to engage other arginine-rich proteins, abrogated PR and NPM1 binding. Using confocal and super-resolution
immunofluorescence microscopy, we found that levels of RAD52, a component of the SSA repair machinery, were
significantly increased iPSC neurons relative to isogenic controls in which the C9ORF72 expansion had been deleted
using CRISPR/Cas9 genome editing. Western analysis of post-mortem brain tissues confirmed that RAD52
immunoreactivity is significantly increased in C9ALS/FTD samples as compared to controls.
Conclusions: Collectively, we characterized the inhibitory effects of DPRs on key DNA DSB repair pathways, identified
NPM1 as a facilitator of DNA repair that is inhibited by PR, and revealed deficits in homology-directed DNA DSB repair
pathways as a novel feature of C9ORF72-related disease.
Keywords: Amyotrophic lateral sclerosis, DNA damage, DNA double strand break repair, Induced pluripotent stem cells,
CRISPR, Single-strand annealing, RAD52, Homology-directed repair
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Background
Despite decades of research and dozens of clinical trials,
amyotrophic lateral sclerosis (ALS) remains a largely un-
treatable disease. There is, therefore, an urgent and unmet
need for more effective therapies. The hexanucleotide
repeat expansion (HRE) mutation in the chromosome 9
open reading frame 72 (C9ORF72) gene is the most com-
mon known cause of ALS and also frontotemporal demen-
tia (FTD) [1–3]. Genetic discoveries have revealed a close
relationship between ALS and FTD indicating that the de-
velopment of an effective therapy for patients with
C9ORF72 ALS is highly likely to benefit patients with
FTD, the second leading cause of dementia. Since the ini-
tial discovery of the HRE, tremendous progress has been
made in unraveling the mechanisms whereby this muta-
tion leads to disease. While C9ORF72 haploinsufficiency
may have a contributory role [4, 5], the weight of available
evidence points towards toxic-gain-of-function exerted by
C9ORF72 RNAs containing the expansion sequence and
dipeptide repeat proteins (DPRs) that derive from non-
canonical translation of the mutant transcripts [6–8].
Of the five DPRs encoded by sense and antisense
C9ORF72 RNAs, proline-arginine (PR) and glycine-
arginine (GR) are particularly neurotoxic as assessed in
multiple model systems including induced pluripotent stem
cell (iPSC) neurons, flies and rodents [6, 9–11]. Analysis of
affected brain tissues also supports a role for PR and GR
[12], yet their precise role in pathogenesis remains contro-
versial [5, 13–16]. The toxicity of arginine-containing DPRs
derives, in part, from their propensity to bind proteins with
low complexity sequence domains that are critical for the
assembly and function of the nucleolus and nuclear pore
complex [16–18]. In vitro, GR and PR localize to the nu-
cleus and disrupt pre-mRNA splicing, ribosomal RNA
(rRNA) biogenesis and alter the global transcriptional pro-
gram, leading to cell death [7, 9, 10]. In addition to these
DPR-mediated anomalies, mutant C9ORF72 RNAs form
G-quadruplex structures that engage RNA binding proteins
including the abundant nucleolar proteins nucleolin (NCL)
and nucleophosmin (NPM1) [19, 20]. These observations
identify nuclear stress as a prominent and persistent cellular
phenotype of C9ALS/FTD that has been observed in pa-
tient tissues [7, 21] and across several model systems [9, 22]
including reprogrammed motor neurons [7] and a mouse
model [13, 23]. While it is best-known as the site of rRNAs
synthesis, the nucleolus also serves as a repository of stress
response effector proteins that can be rapidly mobilized
during cellular perturbations [24–27].
Nucleophosmin (also known as B23) is a multi-
functional nucleolar protein [20, 21, 25, 28] that regulates
nucleolar assembly and function and has been implicated
in C9ALS/FTD [29–33]. The RNA and DNA binding
domains of NPM1, together with nuclear localization and
export signals, facilitate rRNA synthesis, processing and
transport [27]. The amino-terminal portion of NPM1 al-
lows for self-oligomerization, a conformational change
that is facilitated by arginine-rich proteins such as the
tumor suppressor protein p14ARF [34]. Emerging evi-
dence suggests NPM1 participates directly in DNA dam-
age repair in the nucleoplasm [35]. Therefore, arginine-
rich DPRs that bind to NPM1 may confer toxicity in a
multi-modal fashion affecting cellular processes mediated
by NPM1 including rRNA biogenesis, nucleocytoplasmic
transport, nucleolar function, apoptotic signaling, and
DNA damage repair. Notably, NPM1 has a prominent and
established role in all of these processes with the excep-
tion of DNA damage repair, for which its role remains ill-
defined.
The accumulation of DNA DSBs is increasingly recog-
nized as an emerging feature of C9ALS/FTD and also
other neurodegenerative diseases [36, 37], potentially
due to the unique pressure that neurons are under to
maintain genomic stability [38, 39]. As a consequence of
their inability to utilize homologous recombination (the
preferred DNA DSB repair pathway utilized by most
replicating cells), high oxygen consumption, high tran-
scription rates and longevity, neurons must utilize elab-
orate DNA damage response and repair cascades to
maintain genomic integrity [36]. Pathways utilized by
neurons to repair DNA DSBs include non-homologous
end joining (NHEJ) and homology-directed repair path-
ways; the latter being particularly relevant for the repair
of actively transcribed DNA [40–43].. Notwithstanding
this, the elucidation of the specific DNA repair pathways
that are disrupted in C9ALS/FTD and the HRE prod-
uct(s) that are principally involved remains incomplete.
Moreover, it has not previously been established whether
nucleolar dysregulation and nucleolar proteins are linked
to genome instability in C9ALS/FTD. To address critical
gaps in the understanding of C9ORF72-related genomic
instability, we sought to determine whether neurotoxic
DPRs diminish DNA DSB repair efficiency and whether
NPM1 dysregulation is involved.
Methods
Assessment of DNA repair efficiency
The I-SceI expression plasmid and four U-2 OS cell lines
carrying MMEJ, NHEJ, HR, and SSA reporter cassettes
were generous gifts from Dr. Jeremy Stark at the City of
Hope Medical Center. I-SceI based fluorescent reporter
assays were carried out as previously described with
some modifications [44]. Briefly, 200,000 cells per well
were seeded in a 6-well plate. For DPR overexpression,
the following day cells were co-transfected with 1 μg of
I-SceI plasmid and 1 μg of PR, GR, GA or pcDNA3.1+
empty vector using Lipofectamine 2000 CD (Invitrogen,
12,566,014). For small inhibitory RNA (siRNA) knock-
down experiments, cells were co-transfected with 1 μg of
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I-SceI and 20 μM NPM1 or control siRNAs and 1 μg of
PR, GR and GA or pcDNA3.1+ empty vector using Li-
pofectamine 2000 CD. At 48 h after transfection, cells
were washed twice with PBS, detached with 300 μL tryp-
sin, neutralized in medium and immediately subjected to
fluorescence activated cell sorting (FACS) analysis. In
parallel, co-transfection experiments were carried out to
identity and control for potential changes in transfection
efficiency due to DPR overexpression. FACS was per-
formed in a BD LSR-II flow cytometer, and 100,000 cells
were analyzed per sample. Side and forward scatter were
used to eliminate duplets and dead cells. The FCS Ex-
press 6 software suite was used for data analysis and
plotting. Statistical differences between experimental
groups determined by one-way ANOVA followed by
post-hoc test; 6 biological replicates were used for each
experimental group.
Expression of nucleophosmin-GFP fusion proteins
Three cell lines stably expressing different GFP-NPM1
constructs were generated using plasmids obtained from
Addgene (GFP-NPM1-wt (#17578), GFP-NPM1-NESΔ
(#13283), GFP-NPM1-NLSΔ (#13287)). In each case,
200,000 cells were seeded into 6-well plates and trans-
fected with 3 μg of plasmid using Lipofectamine. After
48 h, transfected cells were selected using medium con-
taining 500 μg/mL Geneticin (ThermoFisher, 10,131,035)
and propagated for 3 weeks in vitro. Cells stably express-
ing NPM1-GFP fusion proteins were isolated by FACS
using a BD FACS SORP Aria-II.
Quantification of nucleophosmin and PR sub-cellular
localization
Each U2-OS cell line (GFP-NPM1-wt, GFP-NPM1-
NESΔ, GFP-NPM1-NLSΔ) was seeded into 2 wells of a
12-well plate (80,000 cells per well) and transfected with
1 μg of PR expression plasmid using Lipofectamine. For
siRNA knock-down experiments, cells were transfected
with siRNAs (10 nM) targeting NPM1 or a control siR-
NAs with no known target using Lipofectamine 2000
CD. After 24 h, cells were fixed with 4% paraformalde-
hyde for 10 min, permeabilized and incubated in block-
ing buffer (0.2% Triton-X and 20% goat serum diluted in
antibody buffer) for 40 min. Cells were washed with PBS
and probed overnight with primary antibody (Anti-PR
repeat, ProteinTech, 23,979–1-AP) diluted 1:500 in anti-
body dilution buffer. The next day, cells were washed
with PBS and probed with secondary antibody at a 1:500
dilution (Alexa Fluor-594, ThermoFisher, R37117). After
2 h, cells were washed with PBS and stained with DAPI
(ThermoFisher, R37605) for 5 min. Cells were imaged
using the Cellomics ArrayScan high content imaging
platform. Viable cells were identified using DAPI emis-
sion and threshold settings optimized for nuclear size,
brightness and circularity. Automated image analysis
designated sub-cellular compartments based on high
DAPI emission intensity in the nucleus (circle) and low
intensity in the surrounding cytoplasmic area (ring).
Quantification of GFP and PR emission intensities was
then computed using the circle and ring masks. The
average signal intensity (distribution) throughout the nu-
cleus and cytoplasm was ascertained by normalizing
total signal intensity for each compartment to its area.
To eliminate the confounding effects of high-intensity
image artifacts, values exceeding 3 standard deviations
above the average of all data points were removed from
downstream analysis.
Stochastic optical reconstruction microscopy (STORM)
imaging
Super resolution imaging experiments were carried out
with a Nikon eclipse Ti2 microscope equipped with
Nikon Instruments (NSTORM). For two color dSTORM
imaging, Janelia 646 and Alexa 568 secondary antibodies
were used with MEA STORM imaging buffer and were
imaged continuously with 10,000 frames collected per
filter range at a frequency of 30 ms. The images were ac-
quired using a 100x, 1.49 NA objective, and imaged onto
a Hamamatsu C11440 ORCA-flash 4.0 camera. Storm
analysis was carried out with Nikon Elements Analysis
5.02.01 for identification of molecules. Molecule list files
were then exported from Nikon elements to be further
analyzed using Clus-Doc software in Matlab R2018b.
Cluster analysis, specifically DBSCAN function, was car-
ried out after manually selecting regions of interest.
iPSC culturing and neuronal differentiation
Induced pluripotent stem cells (iPSCs) were propagated
and used to generate neuronal cultures as previously de-
scribed [45]. Briefly, iPSCs were seeded into Matrigel
coated flasks (Corning, 354,277) and supplemented with
mTeSR1 medium (StemCell Technologies, 85,850). Once
cultures reached ~ 80% confluency, cells were lifted using
Gentle Cell Dissociation Reagent (StemCell Technologies,
07174) and transferred to low attachment (Sigma, poly-2-
hydroxyethyl methacrylate, P3932) flasks containing neur-
onal induction media consisting of neurobasal medium
(Life technologies, cat. 21,103–049) supplemented with
2% NeuroCult SM1 (StemCell Technologies, 05711), 100
ng/μl human fibroblast growth factor (bFGF; PeproTech,
100-18B), 100 ng/μl epidermal growth factor (EGF; Pepro-
Tech, AF-100-15) and 5 μg/μl heparin (Sigma-Aldrich,
H3149-25KU). After two weeks, neuronal precursor cells
were transferred to poly-ornithine/laminin coated flasks
and cultured in neuronal maturation media consisting of
DMEM/F12 (ThermoFisher, 11,320,033) supplemented
with 1% N2 (Gibco, A13707–01), 2% NeuroCult SM1
(StemCell Technologies, 05711), 1% Non-essential amino
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acids (Gibco, 11,140–050), 2 μg/ml heparin (Sigma-Al-
drich, H3149-25KU), 1% antibiotic/antimycotic, 0.1 μM
Retinoic acid (Sigma-Aldrich, 302–79-4), 1 μM purmor-
phamine (Sigma-Aldrich, 483,367–10-8), 1 μM cAMP
(Sigma-Aldrich, 60–92–4), 200 ng/ml ascorbic acid
(Sigma-Aldrich, 50–81-7), 10 ng/ml glia-derived neuro-
trophic factor (GDNF; PeproTech, 450–10) and 10 ng/ml
brain-derived neurotrophic factor (BDNF; PeproTech,
450–02). Neurons were cultured for at least 4 weeks in
maturation medium prior to staining and analysis.
Immunocytochemistry
For immunofluorescent visualization of neuronal cul-
tures, mature neurons were gently lifted and transferred
to chamber slides (MatTek, CCS-8). Following a recov-
ery period of 3 days, neurons were fixed by exposure to
4% paraformaldehyde for 10 min, permeabilized for 15
min in 0.2% TritonX in PBS, and blocked for 40 min in
0.2% TritonX and 20% goat serum in antibody buffer.
Cells were gently washed and treated with various pri-
mary antibodies overnight at 4 °C (see Additional file 1
for a full list of antibodies and dilutions used). The next
day, cells were washed with PBS, probed with secondary
antibodies for 2 h, washed in PBS, stained with DAPI
(ThermoFisher, R37605) and mounted.
Confocal image acquisition and analysis
Immunolabeled cells were visualized using a Zeiss LSM
710 confocal microscope with 8-bit depth, 1024 × 1024
frame size; pixel intensity values were averaged 8 times
for 3 Z-stacks at 20x magnification. To quantify γH2AX
and RAD52 signal intensity, values were measured for
every cell within the image field with a minimum of 5
fields per biological replicate. Emission intensity values
were quantified using the open source Fiji software [46].
Briefly, DAPI was used to visualize nuclei and to create
an image mask in Fiji by selecting: process>binary>make
binary; process>binary>watershed. The image mask was
applied to the corresponding γH2AX or RAD52 images
and quantified by selecting analyze>particles>analyze
particles with the following threshold settings: size 10–
150; circularity 0.3–1. Resulting data were transferred to
MatLab to perform normalization and outlier exclusion
(3 standard deviation above mean intensity). Normalized
data were plotted and analyzed by one-way ANOVA or
unpaired Student’s t-test using GraphPad Prism Seven.
Protein isolation from post-mortem tissues and
immunoblotting
Frozen brain tissues were homogenized in M-PER (Ther-
moFisher, 78,501) supplemented with phosphatase and
protease inhibitors (ThermoFisher, 1,862,495 and 78,438).
Quantification of proteins was performed using a BCA kit
(Pierce, 23,227). For immunoblotting, 30 μg of total
protein was loaded into 10% Criterion SDS gels (Bio-Rad,
5,671,034), separated by electrophoresis and transferred to
nitrocellulose (Bio-Rad, 162–0232) membranes in a 20%
methanol solution for 30min at 100 V. Membranes were
blocked in 5% bovine serum albumin for 1 h, and probed
overnight with primary antibodies at 4 °C. After washing,
membranes were probed with horse radish peroxidase
conjugated secondary antibodies for 1 h. To visualize pro-
teins of interest, substrates for enhanced chemilumines-
cent (ThermoFisher, 32,209) were applied to membranes
for 5min prior to X-ray film exposure and development.
Detection of the C9ORF72 hexanucleotide repeat
expansion
The presence of HREs was assessed using repeat primed
PCR and capillary electrophoresis (CE) as reported pre-
viously [47]. Briefly, 30 ng of genomic DNA was ampli-
fied using FastStart PCR master mix (Sigma-Aldrich, 4,
710,436,001), with 7-deaza-dGTP (New England Bio-
labs), Q-solution (Qiagen), DMSO, and magnesium
chloride. Three primers were used: two reverse anchor
primers (MRX-M13R and MRX-R1) and a forward
6FAM-fluorescent (MRX-F) labeled primer. Touchdown
PCR was performed by gradually decreasing the
temperature from 70 °C to 56 °C in 2 °C increments and
3-min extensions. The amplified product was denatured
in Hi-Di formamide and Liz-6000 size ladder then re-
solved using an ABI3730 DNA Analyzer and the data
processed using GeneMapper software.
Primers:
MRX-F FAM- 5′-TGTAAAACGACGGCCAGTCAAG
GAGGGAAACAACCGCAGCC-3′,
MRX-13R 5′-CAGGAAACAGCTATGACC-3′,
MRX-R1, 5′-CAGGAACAGCTATGACCGGGCCCG
CCCCGACCACGCCCCGGCCCCGGCCCCGG-3′.
CRISPR/Cas9 Adeno-associated viral vectors
Four 21-nucleotide gRNAs were designed to excise the
HRE where C9gR-1 and C9gR-2 target the 5′ end of the
repeat and C9gR-3 and C9gR-4 flank the 3′ end of Exon
2. These guides were cloned in pairs into the 3′ end of a
CB-GFP encoding AAV proviral plasmid, each under the
control of a U6 promoter. Two plasmids pAAV-CB-
GFP-C9gR-2-3 and pAAV-CB-GFP-C9gR-2-4 (most effi-
cient at editing HEK293 cells) were used to package
pseudotyped rAAV9 vectors. For the AAV9-pU1a-
SpCas9-RBGpA vector, SpCas9 is under the control of a
U1a promoter with a HA tag and a nuclear localization
signal at its 5′ end while a 3′ rabbit beta-globin polyade-
nylation signal serves as a termination signal.
Detection of genome editing
To detect CRISPR/Cas9 mediated editing of the C9ORF72
HRE, 25 ng of genomic DNA was amplified using forward
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C9var1 (AAAGAGAGGTGCGTCAAAC) and reverse
C9ln1 (GGGAAAGTAAAAATGCGTCG) primers. The
reaction was prepared in a 25 μL volume, consisting of
5 μL 5X Q5 buffer (New England BioLabs Inc.), 0.5 μL 10
mM dNTPs, 0.25 μL Q5 polymerase, and 5 μL 5M Beta-
ine. Amplification was performed using the thermocycling
parameters: 1 cycle: 3 min, 98 °C; 35 cycles: 30 s, 98 °C, 20
s, 63 °C, 45 s, 72 °C; 1 cycle: 7 min, 72 °C. Resulting ampli-
cons were resolved by electrophoreses and visualized with
ethidium bromide and ultraviolet light.
Dot blot and immunolabeling of proline-arginine
Nuclear and cytoplasmic protein fractions were isolated
using the NE-PER kit (ThermoFisher, 78,833) and ap-
plied to nitrocellulose membranes using a vacuum mani-
fold then blocked with 5% dry milk dissolved in TBS-T
for 1 h. Membranes were then probed with primary anti-
bodies (See Additional file 1 for a list of antibodies and
dilutions) overnight at room temperature. The next day,
membranes were washed with TBS-T, probed with sec-
ondary antibodies for 1 h at room temperature, washed
for 15 min, then visualized using chemiluminescence
and X-ray film as described above.
Bisulfite pyrosequencing
Genomic DNA (gDNA) was extracted from iPSC neurons
using DNeasy Blood & Tissue kit (Qiagen, 69,506); 2 μg of
gDNA was treated with bisulfite and analyzed by pyrose-
quencing (EpigenDx Inc.) as previously reported [48].
Levels of cytosine methylation were assessed using custom
assays developed by EpigenDx (ADS3232-FS1 and ADS3
232-FS2) on the PSQTM96HS system. In total, methylation
levels at 16 cytosine residues within the C9ORF72 pro-
moter from − 55 to + 125 base pairs relative to the
C9ORF72 transcriptional start site were quantified.
Immunoassay analysis of poly(GP)
Levels of poly(GP) in human brain tissue lysates were
measured using a Meso Scale Discovery-based immuno-
assay and a MSD QUICKPLEX SQ120 instrument. A
purified mouse monoclonal poly(GP) antibody was used
as both the capture and detection antibody (TALS
828.179, Target ALS Foundation); the capture antibody
was biotinylated and used to coat a 96-well MSD Small
Spot Streptavidin plate, whereas the detection antibody
was tagged with an electrochemiluminescent label (MSD
GOLD SULFO-TAG). Frozen brain tissues were homog-
enized in M-PER (ThermoFisher, 78,501) supplemented
with phosphatase and protease inhibitors (Thermo-
Fisher, 1,862,495 and 78,438). Quantification of protein
concentrations in each sample was performed using a
BCA kit (Pierce, 23,227). Lysates were diluted to the
same protein concentration, and each sample was tested
in duplicate. For each well, the intensity of emitted light,
which is reflective of poly(GP) levels and presented as
arbitrary units, was acquired upon electrochemical
stimulation of the plate. The experimenter was blinded
to the disease status of all samples.
Results
Nucleophosmin associates with the proline-arginine
dipeptide repeat protein in multiple cellular
compartments
When expressed in vitro, PR localizes within nucleoli [9,
10, 22, 49], presumably due to contacts between the basic
arginine residues of PR and acidic residues of NPM1 [50,
51]. Here, we sought to determine whether binding be-
tween PR and NPM1 is dependent upon the nucleolar
micro-environment or if their interaction is independent of
sub-cellular localization. To test this, we used expression
plasmids to generate cell lines that stably express three dif-
ferent GFP-NPM1 fusion proteins: one with an unmodified
NPM1 sequence (Addgene 17,578, wild-type (WT)), a nu-
clear localization signal deletion mutant (Addgene 13,787,
NLSΔ) or a nuclear export signal deletion mutant
(Addgene 13,283, NESΔ). As expected, the NPM1 NESΔ
mutant localized within nucleoli and the nucleoplasm, but
not the cytoplasm. The NPM1 NLSΔ mutant was detect-
able primarily in nucleoli and the cytoplasm while unmodi-
fied (WT) NPM1 localized almost exclusively within
nucleoli (Fig. 1a). When co-expressed with PR, we found
that the sub-cellular localization of PR mirrored that of
each NPM1 construct. Automated microscopy and image
analysis revealed that the nuclear PR intensity, relative to
nuclear area (average intensity), was significantly decreased
(one-way ANOVA: F(2,957) = 15.19, P < 0.0001) in NESΔ
NPM1 expressing cells (Fig. 1b). This unbiased analysis
confirms that PR is more evenly distributed between the
nucleolus and nucleoplasm when co-expressed with NESΔ
NPM1. When co-expressed with NLSΔ NPM1, cytoplasmic
levels of PR were significantly increased (one-way ANOVA:
F(2,956) = 29.32, P < 0.0001), suggesting a direct interaction
between NLSΔ and PR in the cytoplasm (Fig. 1c). To
confirm this, we isolated nuclear and cytoplasmic pro-
teins from cells expressing PR and either WT NPM1 or
NLSΔ NPM1. A dot-blot analysis revealed a significant
increase in cytoplasmic PR levels when co-expressed
with NLSΔ NPM1, as compared to co-expression with
WT NPM1 (Additional file 2D). These results strongly
suggest that a direct interaction occurs between PR and
NPM1 across cellular compartments and that inhibition
of NPM1 by PR occurs globally (Fig. 1a).
Previously, it was found that substituting specific acidic
residues of NPM1 prevents binding between NPM1 and
basic arginine residues of the tumor suppressor protein
p14-ARF [50, 51]. Assuming these acidic residues are also
necessary for the interaction between NPM1 and the ar-
ginine residues of PR, we substituted six acidic residues of
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NPM1 (D34G, D36G, E37G, E39G, E61G, E93G), here-
after referred to as the acidic loop deletion (AΔ). Next, we
generated three additional GFP-NPM1 constructs: a nu-
cleolar localization mutant (GFP-NPM1-NuLSΔ), a
NuLSΔ and AΔ double mutant (GFP-NPM1-NuLSΔ+AΔ)
and an NLSΔ and AΔ double mutant (GFP-NPM1-
NLSΔ+AΔ). The cytoplasmic co-localization of PR and
NPM1 was significantly reduced by the deletion of the
NPM1 acidic loop (unpaired student’s t-test: GFP-NPM1-
NLSΔ+AΔ, P < 0.005; GFP-NPM1-NuLSΔ+AΔ, P < 0.05)
(Fig. 1d,e). Furthermore, unbiased high-content image
analysis revealed a modest but significant decrease in the
levels of PR within nucleoli when NPM1 levels were de-
pleted using a small inhibitory RNA (siRNA) (unpaired
student’s t-test: P < 0.05) (Additional file 2B). The results
of these experiments provide additional evidence that PR
binds directly to NPM1 and show, for the first time, that
this interaction is independent of complex liquid-liquid
phase dynamics that govern nucleolar assembly and
organization [16]. Therefore, the multiple functions of
NPM1 occurring both within nucleoli and other cellular
compartments are likely to be impaired by PR.
Fig. 1 Subcellular localization of PR. a) Representative confocal images of U-2 OS cells stably expressing wild-type NPM1 (WT), NPM1 with
deletions of the nuclear export (NESΔ) or nuclear localization (NLSΔ); NPM1 proteins were fused to GFP (green). Each NPM1 construct was co-
transfected with PR (red) and nuclei stained with DAPI (blue). Automated microscopy and image analysis was used to quantify levels of PR in the
nucleus (b) or cytoplasm (c) as a function of area (average intensity). Statistical significance was assessed by one-way ANOVA and post-hoc test
between each experimental group; n = 2 biological groups, 9 fields per group, ****P < 0.0001; error bars are SEM, dots represent single cells. d)
Representative images of U-2 OS cells stained with DAPI (blue) expressing GFP-NPM1 fusion proteins (green) with deletions of the nuclear
localization (NLSΔ) or nucleolar (NuLSΔ) signals to confer cytoplasmic localization. Cells were immunolabeled with an antibody against PR (red).
e) Nuclear/Cytoplasmic mean fluorescence (Y-axis) for n > 30 cells per mutant cell line (X-axis), n = 3 biological replicates. *P < 0.05; ***P < 0.0005
student’s t-test; error bars are SEM. f) Cartoon (created in PyMOL) with top and side perspectives of the NPM1 (PDB 4N8M) pentamer
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Dipeptide repeat proteins reduce the efficiency of
multiple double strand DNA break repair pathways
To investigate the role of DPRs in DNA DSB repair
pathways, we used a pathway-specific reporter system as
previously described in detail [44]. Briefly, cell lines were
engineered to have inactive GFP cassettes with recogni-
tion sequences for the rare-cutting meganuclease I-SceI.
Expression of I-SceI in these cells causes DNA DSBs to
occur within the GFP cassettes. Due to the design of
each cassette, GFP expression will occur only if the
intended repair pathway is utilized, thus repair efficiency
can be represented by the proportion of GFP expressing
cells that are identified by fluorescence activated cell
sorting (FACS). For the detection of homology-directed
DSB repair events, the removal of non-homologous in-
sertion sequence is required for the restoration of GFP
expression. For the detection of end-joining events, tan-
dem I-SceI sites were placed within a GFP cassette,
therefore, restoration of GFP does not require sequence
homology. Here, four cell lines, each with a unique
pathway-specific DNA DSB reporter cassette were co-
transfected with the I-SceI expression plasmid (Addgene
ID 44026, EJ5GFP) and one synthetic DPR plasmid
expressing GA, GR, PR or an empty control vector. After
72 h, transfected cells were analyzed by FACS to quantify
the number of GFP positive cells. We found that the ef-
ficiency of NHEJ (− 8%, P < 0.0001), but not other path-
ways, was reduced by GR overexpression (Fig. 2) while
over-expression of PR had pronounced inhibitory effects
on NHEJ efficiency (− 28%, P < 0.0001), micro-homology
mediated end joining (MMEJ) (− 23%, P < 0.05), and
SSA (− 22%, P < 0.0001) (Fig. 2). Representative FACS
scatter plots show that the raw percentage of GFP posi-
tive cells after gating was reduced in PR transfected cells
by 1.23% (4.27–3.04%) and 1.6% (4.99–3.39%) for SSA
and NHEJ, respectively (Fig. 2e-h). The efficiency of
homologous recombination (HR) was affected by the
overexpression of DPRs (one-way ANOVA: F3,20 = 4.836,
P = 0.0109), but a post-hoc analysis found no significant
differences between experimental groups and the control
group (Fig. 2a). In contrast, post-hoc analyses found the
efficiency of NHEJ (− 5%, one-way ANOVA: F3,20 =
104.6, P < 0.0001) and SSA (− 9%, one-way ANOVA:
F3,20 = 30.76, P < 0.0001) were significantly reduced by
GA, but the magnitude of inhibition was modest (Fig.
2b,d). To ensure that expression of DPRs does not
Fig. 2 Efficiency of double strand DNA break repair pathways in response to dipeptide repeat proteins. a-d) Relative repair efficiency (Y-axis) as
determined by the percentage of GFP positive cells in cultures transfected with DPR expression plasmids or an empty vector (set to 100%
efficiency). Four reporter cell lines were used to assess the efficiency of (a) homologous recombination (HR), (b) non-homologous end joining
(NHEJ), (c) microhomology mediated end joining (MMEJ), and (d) single strand annealing (SSA). Statistical significance was assessed by one-way
ANOVA and post-hoc test between each experimental group and the control group (vector); n = 6 biological replicates, 100,000 cells/replicate
were evaluated; error bars are SEM, *p < 0.05, ***p < 0.0005, ****p < 0.0001. Inset numbers are the mean difference between groups. E-H)
Representative fluorescence activated cell sorting plots of transfected NHEJ and SSA reporter cells using GFP fluorescence (Y-axis) and side scatter
(X-axis); the number of GFP positive cells is represented as a percentage of parent gating
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interfere with transfection of the I-SceI expression plas-
mid, which could confound our analysis, we performed a
co-transfection control experiment whereby U2-OS cells
were transfected with a GFP expression plasmid and
each DPR expression plasmid. We observed no signifi-
cant difference in the number of GFP expressing cells
across the experimental groups, suggesting that changes
in transfection efficiency cannot explain our finding that
DPRs reduce the efficiency of DNA DSB repair
(Additional file 3).
Nucleophosmin facilitates single strand annealing and
non-homologous end joining
Previous studies have shown that expression of PR in-
creases the frequency of DNA DSBs in cells [52] and that
NPM1 facilitates DNA repair [3, 35, 52], but it is unknown
whether PR confers its genome destabilizing effects
through inhibition of NPM1. Therefore, we sought to de-
termine whether the depletion of NPM1 would increase
the frequency of DNA DSBs and exacerbate the effects of
PR on DNA DSB repair efficiency. While NPM1 has been
generally implicated in DNA break repair [35, 53], no pre-
vious examinations of its role in specific DNA DSB repair
pathways has been reported. We found that depletion of
NPM1 with a siRNA significantly reduced the efficiency of
NHEJ (one-way ANOVA: F [7, 40]=143, P < 0.0001) and
SSA (one-way ANOVA: F [7, 39]=82.98, P < 0.0001)
(Fig. 3). The effects of NPM1 depletion were more pro-
nounced in DPR-expressing cells when compared to
NPM1 siRNA or DPR-expression alone. Efficient NPM1
depletion and PR expression was confirmed by RT-PCR,
western blot, and dot blot (Additional file 4). These results
suggest a role for NPM1 in DNA DSB repair and that PR
and GR may inhibit these pathways through an NPM1-
dependent mechanism. In support of this notion, GR and
PR are known to bind to NPM1 directly [9, 49]. However,
since GA does not bind to NPM1 but had a similar addi-
tive inhibitory effect on DNA DSB repair, the observation
Fig. 3 DNA repair efficiency in response to the manipulation of nucleophosmin levels. a-b) Repair efficiency (Y-axis) as determined by the
percentage of GFP positive cells in cell cultures transfected with proline-arginine (PR), glycine-arginine (GR), glycine-alanine (GA) and
nucleophosmin siRNA, or control siRNA. Two reporter cell lines were used to assess the efficiency of (a) non-homologous end joining (NHEJ) and
(b) single strand annealing (SSA). Statistical significance was assessed by one-way ANOVA and post-hoc test between each experimental group
and the control group (control siRNA); n = 6 biological replicates, 100,000 cells/replicate were evaluated; error bars are SEM, *p < 0.05, ***p <
0.0005, ****p < 0.0001. (c-f) Representative fluorescence activated cell sorting plots of transfected NHEJ and SSA reporter cells using GFP
fluorescence (Y-axis) and side scatter (X-axis); the number of GFP positive cells is represented as a percentage of parent gating
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may simply indicate that DPRs and NPM1 depletion in-
hibit DNA repair through independent mechanisms.
Next, we transfected U-2 OS cells with PR, an NPM1
siRNA, or a combination of both and used immunocyto-
chemistry (ICC) to quantify levels of γH2AX, a well-
established marker of DNA damage, commonly associ-
ated with DNA DSBs. Expression of PR and depletion of
NPM1 significantly increased DNA DSB frequency rela-
tive to un-transfected cells, or cells transfected with an
inactive siRNA (Additional file 5A). Depletion of NPM1
alone enhanced DNA double strand break frequency fol-
lowing exposure to etoposide, further suggesting a role
for NPM1 in DNA DSB repair (Additional file 5B).
Nucleophosmin translocates to sites of single strand
annealing and interacts with the double strand DNA
break repair machinery
A hallmark of nuclear stress is nucleolar disassembly
and dispersal of nucleolar proteins [9, 10, 54]. Previous
studies suggest that cellular stress leads to the dissoci-
ation of NPM1 pentamers in nucleoli and recruitment of
monomeric NPM1 to sites of DNA damage and repair
[27, 35, 53]. We found that NPM1 affects SSA and NHEJ
efficiency (Fig. 3) and sought to determine whether in-
ducing DNA DSBs results in the translocation of NPM1
from the nucleolus to nucleoplasm. To this end, U-2 OS
cells were treated with etoposide (200 μM) for 1 h to in-
duce DNA DSBs. Using super-resolution Stochastic Op-
tical Reconstruction Microscopy (STORM) [55, 56], we
found that levels of γH2AX were robustly increased by
exposure to etoposide, confirming efficient induction
and detection of DNA damage (Additional file 6). Using
an antibody against NPM1, we then assessed NPM1
sub-cellular localization with nanometer accuracy. We
found that levels of NPM1 were dramatically reduced
within nucleoli of cells treated with etoposide (Fig. 4a),
whereas an analysis of the nucleoplasm revealed a highly
significant increase in both the number of NPM1 mole-
cules/cluster and cluster area, indicating disassembly of
the nucleolus and translocation of NPM1 from the
nucleolus to nucleoplasm (Fig. 4b,c). Next, we sought
to determine whether NPM1 associates with phosphor-
ylated RAD52 (pRAD52), a key mediator of SSA. In
mammalian cells, phosphorylation of RAD52 at residue
Y104 increases its affinity for single stranded DNA and
facilitates the annealing of complementary DNA
strands during SSA [57]. We found that exposure to
etoposide increased co-localization of γH2AX and
pRAD52, indicating efficient activation of the SSA path-
way (Additional file 6B). Moreover, we found that eto-
poside significantly increased (student’s t-test: P < 0.01)
the degree of NPM1 and pRAD52 co-localization in the
nucleus of U-2 OS cells, further supporting a role for
NPM1 in SSA (Fig. 4d,e).
DNA DSB repair proteins are elevated in C9ALS iPSC
neurons but not in those with a hypermethylated
C9ORF72 promoter
Having observed that PR reduced the efficiency of NHEJ
and SSA, we sought to determine whether these pathways
are dysregulated in a more relevant cell type. We generated
iPSC motor neurons (iMNs) using two previously-
characterized C9ALS iPSC lines (C9ALS-1, C9ALS-2) from
our unique patient population [48] and quantified levels of
a general marker of DNA damage foci (γH2AX), a marker
of NHEJ (Ku-70) and SSA (pRAD52). Quantification of
γH2AX levels by western analysis revealed a significant in-
crease after 60 days of motor neuron differentiation for
both cell lines as compared to motor neurons derived from
two unaffected control cell lines (Additional file 7A). There
were also increased levels of Ku-70 (Additional file 7B) and
a dramatic increase in the level of pRAD52 [58] for
C9ALS-1 iMNs but not the C9ALS-2 iMNs (Add-
itional file 7C). Previously, we found that levels of DNA
methylation at the C9ORF72 promoter varies during cellu-
lar reprograming of C9ALS patient cell lines and in the
brain of transgenic mice that harbor the human HRE ex-
pansion [48, 59]. To determine whether epigenetic repres-
sion of the C9ORF72 promoter might explain why the
C9ALS-1 iMNs, had a more pronounced enrichment of
DNA DSB markers as compared to C9ALS-2 iMNs, we
used bisulfite pyrosequencing to quantify the level of cyto-
sine methylation across 16 CpG dinucleotides near the
C9ORF72 transcriptional start site. Mean CpG methylation
levels were 17.8 and 57.4% for C9ALS-1 and C9ALS-2
iMNs, respectively (Additional file 7D). This suggests that
epigenetic repression of the C9ORF72 promoter leading to
reduced transcription and DPR production likely accounts
for the reduced levels of DNA DSB markers in C9ALS-2
iMNs. Epigenetic repression of the C9ORF72 locus has
been shown to alter C9ORF72 RNA splicing, DPR produc-
tion and features of the C9ALS/FTD clinical presentation
[60–62]. While based on only two cell lines, our results
suggest C9ORF72 promoter hypermethylation alters DNA
damage phenotypes in C9ALS iPSC neurons as well.
Genome editing of induced pluripotent stem cells
eliminates the C9ORF72 hexanucleotide expansion and
DPR expression in neurons
Having observed variable DNA damage phenotypes across
iPSC cell lines, we sought to excise the C9ORF72 expan-
sion mutation and generate isogenic control cell lines. To
this end, C9ALS iPSCs were transduced with recombinant
adeno-associated viral (AAV) vectors that express the
Cas9 endonuclease and guide RNAs (gRNAs) flanking the
C9ORF72 expansion. After 2 weeks, iPSC cultures were
dissociated, titrated and seeded at low density. Clonal
iPSC colonies were then manually selected, expanded and
screened using end-point PCR with primers spanning the
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Fig. 4 Super-resolution Stochastic Optical Reconstruction Microscopy (STORM) shows nuclear co-localization of nucleophosmin and phospho-
RAD52. a) Representative images of NPM1 immunostaining (green) in the nuclei (white oval traces in top panels) of cells treated with etoposide
or vehicle control. Red boxes indicate area of increased magnification in bottom panels; yellow arrows indicate nucleoli; white arrows indicate
NPM1 clusters. b-c) Quantification of NPM1 clustering within the nucleoplasm of 3 cells with and without etoposide treatment. ****P < 0.0001, as
determined by unpaired student’s t-test, error bars are SEM. d) Representative super-resolution analysis of U2-OS cells treated with etoposide to
induce DNA DSBs or vehicle control then stained with antibodies against NPM1 and pRAD52. Colored heat-map where red indicates positive
spatial overlap of NPM1 and pRAD52 (correlation coefficient r = 1) and blue indicates negative correlation (r = − 1). E) Numerical quantification of
NPM1 and pRAD52 co-localization in the nucleus, n = 10 cells for each condition. Significance was assessed by unpaired student’s t-test (**P <
0.01); error bars are SEM
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expansion mutation and gRNA recognition sequence to
detect editing events. With this strategy, we selected iPSC
clones from one patient cell line (C9ALS-1) for which a
shift from 521 to 321 base pairs was observed - indicating
that genomic editing had occurred (Additional file 8A).
Another technique, repeat primed PCR, was used to amp-
lify the HRE sequence directly. This analysis confirmed
that deletion of the expansion had occurred for one of the
clones (C9ALS-1.11; hereafter referred to as C9ALS-1 iso)
but not two other clones (C9ALS-1.4 and C9ALS-1.8)
(Additional file 8A). We obtained two additional patient-
derived iPSC cell lines from the Cedars-Sinai iPSC core
facility (CS29iALS-C9nxx, CS52iALS-C9nxx; hereafter
referred to as C9ALS-4 and C9ALS-5) and corresponding
isogenic controls (CS29iALS-C9n1.ISOxx, CS52iALS-
C9n6.ISOxx; hereafter referred to as C9ALS-4 iso and
C9ALS-5 iso) that were generated using similar genome
editing methods. We used repeat-primed PCR to confirm
the presence of the HRE in these patient derived iPSC lines
and lack of the mutation in isogenic controls (Add-
itional file 8B). To confirm that genome editing eliminates
DPR expression in isogenic control lines, we generated
cultures of iPSC neurons. As expected, PR expression
was evident in Tuj1 positive neurons harboring the ex-
pansion (HRE+), but not HRE- isogenic controls (Add-
itional file 8C). To further confirm efficient neuronal
differentiation, cultures were stained with ISL-1, a
motor neuron marker and NeuN, a neuronal nuclear
envelope protein (Additional file 9).
The single strand annealing repair pathway is
constitutively activated in C9ALS iPSC motor neurons and
C9ALS/FTD brain tissues
Semi-automated image analysis of C9ALS iMNs derived
from iPSC cell lines with unmethylated C9ORF72 pro-
moters (C9ALS-1, C9ALS-4, C9ALS-5) and their isogenic
controls revealed significantly higher levels of γH2AX (un-
paired student’s t-test: P < 0.0001) relative to isogenic
iMNs (Additional file 10). To investigate whether reduced
SSA efficiency might contribute to this accumulation of
DNA DSBs in HRE+ iPSC neurons, we quantified levels of
pRAD52 and total RAD52 (tRAD52). Relative to isogenic
control lines, HRE+ iPSC neurons had increased levels
(unpaired student’s t-test: P < 0.0001) of pRAD52 (Fig. 5a,
b) and also tRAD52 (Fig. 5c,d).
To determine whether PR-mediated inhibition of SSA ef-
ficiency (Fig. 2) and hyperactivation of SSA in HRE+ iPSC
neurons (Fig. 5) is indicative of SSA dysregulation in the
brain of C9ALS/FTD patients, we isolated protein from
three regions of post-mortem tissues: motor cortex, occipi-
tal cortex, or cerebellum (sample identifiers and demo-
graphic information are summarized in Additional file 11).
In a comparison between diagnosis groups, we observed in-
creased RAD52 levels in C9ALS samples for all three brain
regions (Fig. 6). In a mixed effect analysis accounting for
between-region and within-person correlation, a significant
increase in RAD52 levels was observed for C9ALS samples
as compared to unaffected controls (p = 0.004) and sALS
(p = 0.035). In a brain-region-specific analysis, increased
RAD52 levels in C9ALS samples reached significance for
the occipital cortex compared to unaffected controls (one-
way ANOVA, p = 0.0023) and sALS (one-way ANOVA,
p = 0.0119), but not other regions due to a high degree of
variability among samples (Additional file 12). Levels of ac-
tivated pRAD52 were also highly variable across the tissue
cohort (Additional file 12), likely due to aberrant phosphat-
ase activity that is known to occur in post-mortem tissues
[63, 64]. Similarly, levels of 53BP1 were highly variable and
did not statistically differ between diagnosis groups (Add-
itional file 12). To confirm expression of DPRs in brain tis-
sue lysates from individuals in the clinical cohort, a Meso
Scale Discovery-based immunoassay was used to measure
glycine-proline DPRs [poly(GP)] in each brain region and
diagnosis group. Poly(GP), one of the more abundant DPRs
in C9ALS brain tissue [15, 65–68], is produced by repeat
associated non-ATG translation of both the sense and anti-
sense HRE transcripts. Consistent with prior findings,
poly(GP) levels were significantly higher in C9ALS patient
tissues compared to CTL and sALS samples, with levels be-
ing the most pronounced in the cerebellum (Add-
itional file 13) [65, 69].
Discussion
Nucleolar dysfunction is recognized as a key feature of
C9ORF72-related neurodegeneration and, as a conse-
quence of this dysfunction, various inter-related cellular
processes are affected [13]. While there is substantial evi-
dence supporting a role for dysregulated RNA metabolism
and nucleocytoplasmic transport defects in C9ALS/FTD
[10, 16], accumulating evidence supports a role for aber-
rant DNA DSB repair as well [52, 70–73]. Since the nucle-
olus is a repository of stress response proteins, and
nucleolar proteins directly participate in the restoration of
homeostasis [24, 27], we sought to investigate the role of
NPM1 in DNA DSB repair deficiencies in C9ALS/FTD fo-
cusing on the role of arginine-rich DPRs that are most fre-
quently associated with nucleolar dysfunction [9, 10]. We
found that a synthetic PR construct co-localizes with
NPM1 in the nucleolus, but also the nucleoplasm and
cytoplasm (Fig. 1). Inhibition of NPM1 by PR across cellu-
lar compartments could interfere with multiple cellular
processes involving NPM1 including rRNA biogenesis,
nucleolar liquid-liquid phase dynamics, nucleocytoplasmic
transport, apoptotic signaling and DNA damage repair,
thereby conferring toxicity.
While many of these processes have already been im-
plicated in C9ALS/FTD, there is increasing interest in
the role of genomic instability resulting from genotoxic
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DNA DSBs and/or reduced DNA DSB repair efficiencies
as a common feature of neurodegenerative diseases [36,
37, 39, 74, 75]. Increased DNA DSB frequency with a con-
comitant activation of response and repair machinery has
been observed in C9ALS/FTD clinical tissues, iPSC motor
neurons, and cells expressing synthetic DPRs [52, 71, 72].
Assessments of C9ALS/FTD spinal cord tissues demon-
strate enrichment of γH2AX [52, 72], poly(ADP-ribose)
polymerase 1 (PARP-1) and P53 binding protein 1
(53BP1) [52]. Enrichment of γH2AX and phosphorylated
P53 has also been observed in C9ALS motor neurons [71].
While there is general consensus that arginine-rich DPRs
are neurotoxic, the degree of GA toxicity has been de-
bated and its role in DNA damage is unclear. Lopez et al.
found that GA overexpression did not increase DNA
DSBs in control iPSC neurons, as determined by comet
assay [71] while Walker et al. found that GA overexpres-
sion increased γH2AX levels both in vitro and in the ro-
dent brain [73]. Recent findings also support a role for GA
in aberrant ATM signaling and increased DNA DSB [76].
Fig. 5 Expression of activated and total RAD52 in C9ALS/FTD neurons. a) Quantification of pRAD52 mean fluorescence in neurons using
automated image analysis software (Fiji/Image J) for three C9ALS iPSC lines normalized to isogenic lines; each data point represents one cell. b)
Representative confocal immunofluorescence images of iPSC motor neuron cultures stained with an antibody against phospho-RAD52 (pRAD52)
(green) and counter-stained with DAPI (blue) scale bars are 100 μm. c) Quantification of total RAD52 (tRAD52) mean fluorescence normalized to
isogenic line. d) Representative images of iPSC motor neuron cultures immuno-stained with an antibody against RAD52 (tRAD52) (green) and
DAPI (blue). n = 3 biological replicates, 5 fields per replicate, error bars are SEM; ****P < 0.0001, as determined by unpaired student’s t test
Andrade et al. Molecular Neurodegeneration           (2020) 15:13 Page 12 of 18
These discrepancies might be explained by the use of dif-
ferent cell types, number of dipeptide repeats used, and
degree of overexpression. Moreover, these previous stud-
ies, have largely assessed levels of DNA repair proteins or
aberrant DNA damage response signaling but did not
evaluate the efficiency of specific repair pathways directly.
Therefore, to better define the role of DPRs in DNA DSB
repair pathways, we used a functional I-SceI DNA DSB re-
pair assay to evaluate the efficiency of all major DNA DSB
repair pathways in the presence of DPRs. We show that
PR robustly reduced the efficiency of SSA and NHEJ, two
pathways utilized by neurons. We also found that GA and
GR significantly reduced NHEJ efficiency, while GA also
significantly reduced SSA (Fig. 2). One limitation of these
experiments is the utilization of immortalized U-2 OS
cancer cell lines that may not accurately model neuronal
DNA DSB repair. To address this limitation and confirm
our findings in more disease-relevant model systems, we
interrogated levels of RAD52 in patient-derived neurons
and isogenic control lines. We found that genome editing
reduces the accumulation of DNA DSBs and RAD52 hy-
peractivation. It should be noted, however, that this ap-
proach eliminates all potentially toxic HRE products
including mutant C9ORF72 mRNA, antisense RNA and
all five DPRs. Thus, we cannot attribute the reversal of ac-
tivated pRAD52 and total RAD52 signaling in C9ALS/
FTD iPSC neurons to the loss of DPRs alone. While we
observed a high degree of variability in the expression of
Fig. 6 Quantification of total RAD52 in human brain samples. a) Western blot quantification of total RAD52 from unaffected controls (CTL),
C9ORF72-related ALS (C9ALS) and sporadic ALS (sALS) in three different brain regions: Occipital cortex (OC) Cerebellum (CB) and Motor cortex
(M1). Comparisons between diagnosis groups were performed by mixed effect analyses utilizing data from all three brain regions and accounting
for both the between-region differences and within-person correlation; n = 6 per diagnosis group, 3 measurements per person, one from each
region. b) Representative western for total RAD52 and beta-actin
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RAD52 across clinical samples, a statistically significant
increase was found in C9ALS samples, as compared to un-
affected controls or sALS samples (Fig. 6). Our observa-
tion that RAD52 is elevated in all brain regions, including
those typically assumed to be unaffected, is not unex-
pected. Even the most prominent molecular features of
C9ALS/FTD (e.g. DPRs and RNA foci) have a confound-
ing relationship with clinicopathology. It is widely recog-
nized that the presence or levels of DPRs are not
predictive of the degree of neurodegeneration in a given
region of the CNS. Apparently, resistance to toxicity varies
across cell types and brain regions, for unknown reasons
[77]. Our analysis of clinical brain tissues confirmed in-
creased expression of both RAD52 and poly(GP) in all
C9ALS/FTD samples (Additional file 13). The limited
number and quality of the sample cohort used in this
study is a potential weakness (Additional file 11).
In replicating cells, NPM1 is recruited to sites of DNA
damage where it co-localizes with components of repair
machinery including γH2AX, BRCA1 and ring finger 8
and 168 (RNF8/RNF168) [53, 78]. Moreover, NPM1
loss-of-function destabilizes the genome [79–82] while
overexpression enhances DNA repair capacity and im-
proves survival of cells exposed to ultra-violet radiation
[83]. Conversely, reduced NPM1 function increases radi-
ation sensitivity in vitro and stalls DNA DSB repair, sug-
gesting NPM1-mediated repair may be rate limiting [53,
84]. Consistent with the protective role of NPM1 in
C9ALS/FTD, Farg et al. found that overexpression of
NPM1 reduced pro-apoptotic signaling in response to
ectopic PR expression [52]. These studies, and those of
others [35, 52, 74, 78, 85] implicate NPM1 in DNA dam-
age repair, although its role in specific DNA DSB repair
pathways has not been sufficiently addressed. Here we
show that chemical induction of DNA DSBs in vitro re-
sults in the translocation of NPM1 from nucleoli to the
nucleoplasm where it co-localizes with pRAD52, a specific
marker of SSA (Fig. 4). Moreover, depletion of NPM1 sig-
nificantly reduces the efficiency of NHEJ and SSA (Fig. 3),
thereby implicating a ubiquitous role for NPM1 in both
homology-directed and non-homologous repair pathways.
Our data support the notion that DPRs impair DNA DSB
through inhibition of NPM1’s role in DNA DSB repair
(Additional file 14). To our knowledge, ours is the first
study to link NPM1 to SSA. Future studies will be needed
to fully disentangle the multifaceted role of NPM1 in
C9ALS/FTD and its mechanistic role in SSA.
In addition to NPM1, several ALS-linked RNA binding
proteins have direct roles in DNA DSB repair including
valosin-containing protein (VCP), fused in sarcoma
(FUS) and TAR DNA binding protein 43 (TDP-43) [70,
72, 86–92]. It is increasingly understood that the RNA
processing functions of these proteins are capable of de-
stabilizing co-transcriptional structures called R-loops,
which are composed of the nascent RNA hybridized
with template DNA and the non-template single-
stranded DNA, thereby reducing the potential of persist-
ent R-loops to result in DNA DSBs [73, 93, 94]. In
addition to preventing DNA DSBs from occurring dur-
ing transcription, these proteins may also facilitate
transcription-associated homology-directed repair in
post-mitotic neurons [41, 42, 92]. Interestingly, RAD52
plays a key role in RNA-coordinated DNA DSB repair
by tethering complementary single strand DNA and
RNA to facilitate annealing during homology-directed
repair and has been linked to R-loop processing and
transcription-associated repair [40, 42, 43, 95, 96]. Thus,
nascent RNAs, RNA binding proteins, and RAD52 have
key roles in maintaining the integrity of active neuronal
genes, roles that are compromised by the presence of
DPRs. Our findings support this model by 1) demon-
strating that DPRs inhibit DSB repair efficiency, 2) indi-
cating that NPM1 facilitates homology-directed DNA
DSB repair and 3) identifying constitutively active
RAD52 as a novel molecular phenotype in C9ALS/FTD.
Future studies will be needed to fully elucidate the role
of NPM1, FUS, TDP-43 and other ALS-linked RNA
binding proteins in preventing R-loop associated DNA
DSBs as well as their role in facilitating homology-
directed DNA DSB repair.
Conclusions
Here we show that C9ORF72 DPRs inhibit multiple
DNA DSB repair pathways that are utilized by post-
mitotic neurons to maintain genomic integrity
throughout their extended lifetime. In addition to
identifying aberrant homology-directed DNA DSB re-
pair as a novel C9ORF72-related disease mechanism,
we show that impairment of SSA is partially mediated
through NPM1 inhibition. Lastly, these results sup-
port emerging evidence that RNA binding proteins
like NPM1 and homology-directed repair machineries
including RAD52 play critical roles in RNA-directed
DNA DSB repair.
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Additional file 1. Antibody applications and dilutions.
Additional file 2 Nucleolar localization of PR is dependent on NPM1
expression. A) Representative images of U-2 OS cells transfected with a
plasmid expressing HA-PR (PR) and immunolabeled with anti-PR (red)
and anti-nucleophosmin (NPM1) (green) antibodies. Localization of the
nucleus DAPI (blue), NPM1 (green), and PR (red) were visualized by con-
focal microscopy. B) Nuclear PR mean fluorescence intensity is signifi-
cantly reduced in NPM1 siRNA treated cells when compared to control
siRNA treated cells. C) NPM1 knock down significantly reduces mRNA
levels determined through real time PCR. Cytoplasmic PR levels are in-
creased when co-expressed with GFP-NPM1-NLSΔ. D) Quantification of
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dot blot for PR in the cytoplasm relative to GAPDH. Significance calcu-
lated using student’s t-test, n = 3 biological replicates; error bars are SEM;
*P < 0.05, ****p < 0.0001.
Additional file 3 Transection efficiency is not altered by DPR expression.
U2-OS cells were co-transfected with a GFP expression plasmid (1 μg)
and either pcDNA, PR, GR, or GA plasmids (1 μg). Using FACS, we quanti-
fied the number of GFP expressing cells and found no significant change
in the number of GFP expressing cells between groups, indicating that
DPRs do not alter the transfection efficiency of other plasmids. Three rep-
licates for each experimental group; n > 50,000 cells/sample; error bars
are SEM.
Additional file 4. Validation of NPM1 knockdown and PR
overexpression. In parallel with the quantification of SSA and NHEJ (Fig.
3), a subset of cells were transfected with either a control (CTL) siRNA, a
NPM1 specific siRNA, an empty control vector (vector) or a PR expression
vector (PR). (A) To confirm NPM1 depletion, RNA was extracted from
three biological replicates and analyzed by real-time RT-PCR using the
relative quantification method where GAPDH served as the endogenous
control. Cells transfected with the NPM1 siRNA has significantly lower
levels of NPM1 mRNA (****p < 0.0001). (B) Also in parallel, proteins were
isolated from two biological replicates and analyzed by western blot.
Relative to the endogenous control (Actin), NPM1 levels were drastically
reduced. (C) To confirm the overexpression of PR in cells transfected with
the PR overexpression vector (PR) or an empty control vector (vector),
the insoluble nuclear protein fraction was isolated and a slot-blot was
performed, hybridized with the anti-PR antibody then visualized by
chemiluminescence. A robust increase in PR expression was readily
observed.
Additional file 5 PR overexpression and NPM1 depletion increase levels
of the DNA double strand break marker γ-H2AX. A) Western blot analysis
of U-2 OS cells co-transfected with the HA-PR plasmid and an NPM1
siRNA at 48 h. B) Western blot analysis of U-2 OS etoposide treated cells
with or without NPM1 siRNA. C) Western blot used for A and B quantifi-
cations. **P < 0.005, ***P < 0.0005 relative to pcDNA3.1+ control; n = 3
biological replicates, one-way ANOVA followed by Tukey’s post-hoc test;
error bars are SEM.
Additional file 6. Validation of DNA damage induction. A) DNA double
strand break inducers validated through immunoblotting. B) Super
resolution (STORM) microscopy reveals increased γH2AX (red) and
phosphorylated RAD52 (green) immunofluorescence and co-localization
(yellow) in the nucleus of U-2 OS cells treated with etoposide.
Additional file 7 Quantification of DNA damage markers in patient
derived motor neurons. Western blot analysis of total protein lysates from
motor neurons derived from two iPSC lines from unaffected controls
(CTL-1, CTL-2) and two lines from C9ALS patients (C9ALS-1, C9ALS-2) re-
solved by electrophoresis and immunolabeled with antibodies against a
marker of DNA damage foci, γH2AX (A), a marker of non-homologous
end joining recombination repair, Ku70 (B) or single strand annealing,
RAD52 (C). Statistical significance was assessed by one-way ANOVA and
post-hoc test between each group; n = 2 biological replicates; error bars
are SEM; *p < 0.05, **p < 0.005, ***p < 0.0005, ****p < 0.0001. D) DNA
methylation analysis of CpG dinucleotides at the C9ORF72 promoter. Re-
duced DNA DSB markers for C9ALS-2 neurons is associated with in-
creased CpG methylation at the C9ORF72 promoter.
Additional file 8. Genome editing eliminates the C9ORF72
hexanucleotide repeat expansion. A) Schematic of editing strategy:
adeno-associated viral (AAV) transduction of iPSCs derived from a C9ALS/
FTD patient, titration, clonal selection and isolation of genomic DNA for
downstream analysis. Location of guide RNAs and PCR primers spanning
the HRE. Expected amplicon sizes for the wild type (WT), expanded and
edited alleles are indicated. Electrophoresis of PCR amplicons from three
iPSC clones C9ALS-1.4 (HRE+/wt-), C9ALS-1.8 (HRE+/wt+), C9ALS-1.11
(HRE−/wt-) using C9 flanking primers (top) or template input control
primers (bottom). Sanger sequencing of PCR amplicons from clone
C9ALS-1.11 (HRE−/wt-) confirms loss of sequence homology to the refer-
ence genome between gRNAs. Schematic of repeat primed PCR amplifi-
cation of the HRE. Fragment analysis of amplicons for three clones
confirms the loss of the HRE in clone C9ALS-1.11. B) Electropherogram
output from fragment analysis indicating intensity (Y-axis) and size (X-axis)
of amplicons produced by C9ORF72 repeat-primed PCR. Source of tem-
plate genomic DNA corresponding to each iPSC cell line used in the
study is indicated in upper-right corner. Prototypical saw-tooth pattern is
evident in three patient derived cell lines with the hexanucleotide expan-
sion (C9ALS-1, C9ALS-4, C9ALS-5) and lack of PCR products in gnomically
edited cell lines (iso). analysis of amplicons for all 6 cell lines clones the
loss of the HRE in all isogenic clones. C) Representative images of motor
neurons from six iPSC lines stained for DAPI (blue) and immunolabeled
with antibodies against Tuj1 (green) and PR (red).
Additional file 9. Expression of neuronal markers in iPSC motor neuron
cultures. Representative images of neuronal cultures stained DAPI (blue)
and antibodies against the neuronal nuclear envelope marker protein
NeuN (top panels) and the motor-neuron specific marker ISL-1 (bottom
panels).
Additional file 10 Quantification of DNA damage foci in C9ORF72 iPSC
neurons. A) Representative images of iPSC neuronal cultures immuno-
stained with γH2AX (green), Tuj-1 (red) and DAPI (blue). B-D) Quantifica-
tion of γH2AX mean fluorescence normalized to isogenic line; n = 2, 5
fields; error bars are SEM; ****P < 0.0001, as determined by unpaired stu-
dent’s t test.
Additional file 11. Target ALS Human Postmortem Brain Tissue Cohort.
Target ALS Human Postmortem Brain Tissue Cohort. All diagnoses and
identifiers were the same for the three brain regions provided (occipital
cortex, cerebellum, and motor cortex).
Additional file 12 Quantification of phosphorylated RAD52 and 53BP1
in human brain samples. Quantification of pRAD52 (A,B) and 53BP1 (C,D)
as assessed by western analysis of protein lysates from unaffected
controls (CTL), C9ORF72 related ALS (C9ALS) and sporadic ALS (sALS);
three different brain regions: Occipital cortex (OC) Cerebellum (CB) and
Motor cortex (M1). Comparisons between diagnosis groups were
performed by mixed effect analyses utilizing data from all three brain
regions and accounting for both the between-region differences and
within-person correlation; n = 6 per diagnosis group, 3 measurements
per person – one from each region. E) One-way ANOVA Tukey’s post-hoc
comparison between diagnosis groups for each brain region.
Additional file 13 Quantification of poly(GP) in human brain samples.
A) Quantification of poly(GP) in protein lysates from unaffected controls
(CTL), C9ORF72 related ALS (C9ALS) and sporadic ALS (sALS) in three
different brain regions: Occipital cortex (OC), Cerebellum (CB) and Motor
cortex (M1). Poly(GP) levels were measured using a Meso Scale Discovery
– based immunoassay. Each sample was measured in duplicate and the
mean values are represented. Comparisons between groups were
performed by one-way ANOVA for each brain region. N = 6 per diagnosis
group, 3 measurements per person – one from each region. **** = P <
0.0001 B) One-way ANOVA Tukey’s post-hoc comparison between diag-
nosis groups for each brain region.
Additional file 14. Model of DPR-mediated inhibition of DNA DSB re-
pair. In nucleoli, PR binds and stabilizes NPM1 pentamers by binding to
the acidic loop of NPM1 in a similar way that endogenous arginine-rich
proteins like ARF bind and stabilize NPM1. Since NPM1 facilitates DNA
DSB repair in the nucleoplasm as a monomer, we hypothesize that PR in-
hibits DNA DSB repair, in part, by preventing the translocation of NPM1
from the nucleolus to the nucleoplasm.
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